These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5653948)

  • 1. Antimalarial treatment of rheumatoid arthritis.
    Zvaifler NJ
    Med Clin North Am; 1968 May; 52(3):759-64. PubMed ID: 5653948
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI
    J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimalarials in rheumatology: efficacy and safety.
    Maksymowych W; Russell AS
    Semin Arthritis Rheum; 1987 Feb; 16(3):206-21. PubMed ID: 3547658
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.
    Arden GB; Kolb H
    Br Med J; 1966 Jan; 1(5482):270-3. PubMed ID: 5902055
    [No Abstract]   [Full Text] [Related]  

  • 5. Current practice in antimalarial drug prescribing in rheumatoid arthritis.
    Bellamy N; Brooks PM
    J Rheumatol; 1986 Jun; 13(3):551-5. PubMed ID: 3735276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of a practical use of synthetic antimalarials in the treatment of rheumatoid polyarthritis].
    David-Chaussé J; David-Chaussé F; Picot C; Laporte G; Lagoarde J; Dehais J
    Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):681-90. PubMed ID: 5151168
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract]   [Full Text] [Related]  

  • 8. Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?
    Schwartzman S; Samson CM
    Rheum Dis Clin North Am; 2019 Aug; 45(3):359-367. PubMed ID: 31277749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ophthalmic side effects of chloroquine in patients with rheumatoid arthritis].
    Sarmela T; Kajander A
    Duodecim; 1968; 84(5):306-11. PubMed ID: 5670747
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.
    Costedoat-Chalumeau N; Dunogué B; Leroux G; Morel N; Jallouli M; Le Guern V; Piette JC; Brézin AP; Melles RB; Marmor MF
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):317-26. PubMed ID: 25672591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 13. The prescribing of chloroquine and hydroxychloroquine by consultant rheumatologists in the UK.
    Kay EA; Rees JA; Jayson MI
    Br J Rheumatol; 1987 Oct; 26(5):375-8. PubMed ID: 3664163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A
    Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients opinion and adherence to antimalarials in lupus erythematosus and rheumatoid arthritis treatment.
    Cabral RTS; Klumb EM; Carneiro S
    J Dermatolog Treat; 2020 May; 31(3):264-269. PubMed ID: 30935255
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
    Laaksonen AL; Koskiahde V; Juva K
    Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of synthetic antimalarial drugs and other agents for rheumatoid arthritis: historic and therapeutic perspectives.
    Scherbel AL
    Am J Med; 1983 Jul; 75(1A):1-4. PubMed ID: 6346869
    [No Abstract]   [Full Text] [Related]  

  • 18. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
    Tzekov R
    Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.
    KERSLEY GD
    Proc R Soc Med; 1964 Aug; 57(8):669-71. PubMed ID: 14195851
    [No Abstract]   [Full Text] [Related]  

  • 20. [The changes in the electric retinal activity during resochin treatment].
    Svĕrák J; Peregrin J; Salavec M
    Klin Monbl Augenheilkd; 1967 Nov; 151(5):633-40. PubMed ID: 5597424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.